Conflicting Federal Signals: Rescheduling & Political Signaling

“Trump Privately Committed to Reschedule Marijuana ‘Multiple Times’”
Scotts Miracle-Gro CEO James Hagedorn says President Trump has privately assured stakeholders more than once that he intends to reschedule marijuana from Schedule I. These promises stand in stark contrast to public inaction. Link.

“Trump’s New DEA Administrator Omits Cannabis Rescheduling”
Despite pledging during his confirmation hearing to prioritize cannabis rescheduling, DEA Administrator Terrance Cole failed to include it in his list of eight strategic priorities—opting instead to focus on enforcement, terrorism, and drug trafficking. Link.

“Trump Backs Pro‑Marijuana Legalization Lawmaker as RNC Chair”
Trump formally endorsed Joe Gruters, a vocal supporter of legalization, to chair the Republican National Committee—signaling a shift in political messaging and an attempt to connect with younger or moderate Republican voters. Link.

Key Takeaway:

• The federal outlook on marijuana resembles a game of whispers and misalignments. Debt-ridden commercial players may hear the rhetoric—but too often find it too weak to base growth strategies upon.

Financial Infrastructure Pressure: Banking Reform Momentum

“Bipartisan Coalition of 32 Attorneys General Call for Federal Cannabis Banking Reforms”
Attorneys general from 32 states and territories sent a joint letter urging Congress to pass the 2025 SAFER Banking Act. They warned that conducting the cannabis business almost entirely in cash poses serious public safety, tax compliance, and regulatory transparency risks. Link.

Strategic Insight:

• With momentum building, operators should examine how they currently manage financial risk, and consider aligning with broader regulatory reform efforts for long-term access to banking and cost-saving efficiencies.

Trust Erosion Through Compliance Failures & Regulatory Mistakes

“New York Regulators Miscalculate Dispensary Distances”
New York’s Office of Cannabis Management announced that over 150 retailers—including 105 operational shops—were located too close to schools due to faulty proximity calculations. Though a $15 million relocation fund has been mobilized, many fear impending business disruption. Link.

“Cannabis Testing Laboratories Sue Equipment Maker Alleging Fraud”

More than two dozen U.S. testing labs have filed lawsuits against PerkinElmer (now Revvity), claiming that the company sold unreliable or misleading lab equipment, causing widespread chain-of-custody and accuracy concerns. Link.

“DEA Promotes Claim That Marijuana Causes Depression and Suicide”
Shortly after Terrance Cole took office, DEA promoted an article linking cannabis use to depression and suicidal ideation—despite extensive research pointing toward balanced outcomes. Critics say this undermines public confidence in factual regulation. Link.

“Fake Cannabis Licenses Sold to Roughly 70 Businesses in Connecticut”
Connecticut Attorney General filed suit against individuals accused of selling bogus cannabis licenses to around 35–70 businesses, charging each between $25,000–$30,000 via forged documents. The scam exposed glaring weaknesses in state-level due diligence. Link.

Takeaway:

• From state agencies to lab operators, breaches of diligence and oversight are eroding industry credibility. Proactive auditing and transparency will increasingly separate trusted brands from liability-prone counterparts.

Industry Evolution: New Models & Market Consolidation

“Cannabis Retailers See Sales Surge with New Shopping Models”
Retailers like Verano Holdings are adopting “bodega-style” layouts and “sniff‑jar” sensory experiences to make cannabis shopping more intuitive and less intimidating. Early results show increased basket size and product discovery behaviors. Link.

“Marijuana MSO AYR Wellness Will ‘Cease to Exist’ After Sell‑Off”
Analysts report that MSO AYR Wellness may dissolve in its current form as it sells assets to satisfy debt. The restructuring reflects growing pressure on cash‑tight operators amid federal stagnation. Link.

Key Takeaway:

• Not all growth is guaranteed: while some retailers redefine consumer expectations and thrive, others—like AYR—are scaling back amid waning capital access and shifting balance sheets.

  
  

Business Model Divergence

📣 We Want Your Voice!

Reply or comment to share your view on:

• How do you evaluate risk in jurisdictions with inconsistent regulatory track records?

• Is your operation planning around potential banking reforms—if, or when, they arrive?

  
  

• With trust under threat, what internal controls or public-facing messages are you strengthening?

Stay informed. Stay compliant. Keep growing.

Jared Schwass